Talarozole (R115866)

Talarozole (R115866) is an inhibitor of Retinoid Receptors used in studies of nuclear-receptor signaling. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to ligand-dependent transcriptional control and receptor co-regulation in developmental biology, endocrinology, and metabolism models.

By inhibiting Retinoid Receptors, Talarozole (R115866) can be used to examine ligand-dependent transcriptional control and receptor co-regulation. This target class is commonly examined through reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping. In developmental biology, endocrinology, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Retinoid Receptors
• Concentration-response inhibition and target-dependence studies
• Reporter-gene, receptor-binding, and transcriptional assays
• Phenotypic profiling in developmental biology, endocrinology, and metabolism models

Overall, Talarozole (R115866) is appropriate when a defined chemical perturbant is needed to connect Retinoid Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in developmental biology, endocrinology, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.